Related Experiment Videos
Chronic thromboembolic pulmonary hypertension.
P Dartevelle1, E Fadel, S Mussot
1Dept of Thoracic and Vascular Surgery and Heart-Lung Transplantation, Marie Lannelongue Hospital, Paris-Sud University, Le Plessis Robinson, France. pdartevelle@ccml.com
The European Respiratory Journal
|April 16, 2004
Summary
Chronic thromboembolic pulmonary hypertension (CTEPH) is treatable with pulmonary thromboendarterectomy. This surgery offers definitive, excellent functional results for patients with CTEPH.
Area of Science:
- Cardiology
- Thoracic Surgery
- Pulmonology
Background:
- Pulmonary arterial hypertension (PAH) is a severe condition gaining attention due to new therapies.
- Chronic thromboembolic pulmonary arterial hypertension (CTEPH) is a potentially curable form of PAH.
- Surgical advancements have improved patient outcomes and quality of life.
Purpose of the Study:
- To highlight the efficacy of pulmonary thromboendarterectomy for CTEPH.
- To discuss the diagnostic challenges and methods for CTEPH.
- To outline the surgical procedure and its success rates.
Main Methods:
- Diagnosis involves lung scintiscan for perfusion defects and pulmonary angiography to assess lesion location.
- Pulmonary thromboendarterectomy is performed under hypothermia and total circulatory arrest.
- Angiography technique requires capturing the entire arterial tree for surgical planning.
Main Results:
- Pulmonary thromboendarterectomy can cure CTEPH with minimal perioperative mortality.
- The procedure provides definitive and excellent functional results in most cases.
- Successful endarterectomy depends on lesion location (proximal vs. distal) and hemodynamic significance.
Conclusions:
- CTEPH is a surgically curable condition.
- Pulmonary thromboendarterectomy is a highly effective treatment for CTEPH.
- Accurate diagnosis and surgical planning are crucial for successful outcomes.